Vedolizumab Not Associated With Increased Risk of C Diff in

Vedolizumab Not Associated With Increased Risk of C Diff in Patients With IBD, Study Finds

Vedolizumab Not Associated With Increased Risk of C Diff in Patients With IBD, Study Finds

hcplive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hcplive.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Saudi Arabia , Canada , Saudi , Abdulaziz Saad Alshahrani , Narulan Vedolizumab , Gastroenterology At Najran University In , Mcmaster University Medical Centre , Virtual Medical Academy Abdulaziz Saad Alshahrani , Centers For Disease , Virtual Medical Academy , Najran University , Interquartile Range , Hazard Ratio , Confidence Interval , Pharmaceutical Journal , Disease Control , Accessed September ,